RePORT International What’s New

This is a summary of TB research presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, CO, from 22 to 25 February 2026.

While discussions on TB often focus on epidemiology, surveillance, and control, this session brings forward the human dimension of this disease. Through their personal journeys of diagnosis, treatment, and recovery, survivors share the real-life challenges of living with zoonotic TB. Their stories reveal important social, cultural, and health system barriers, and emphasize the need for faster and integrated One Health approaches to prevention and control.

This seminar focused on the civil society space and the critical role it is playing: amplifying community voices, holding systems accountable, and bridging the gap between policy and results. Examples were shared from Zimbabwe, Nigeria, and Kenya.

This is a summary of the presentations from the TB Alliance Global TB Stakeholders meeting on March 4, 2026.

With the Global Fund Grant Cycle 8 (GC8) now open, this factsheet comes at a critical time for countries preparing funding requests, cost roadmaps, and advocacy strategies to secure NPOC rollout. GC8 is a critical opportunity to shape how new TB diagnostics are financed and deployed over the next grant cycle. TAG‚ new factsheet gives advocates the tools needed to succeed: clear budget language, use case illustrations, advocacy questions for country dialogues, and a step-by-step timeline spanning the full funding cycle.

A new implementation toolkit for NPOC-NAAT and swab-based TB testing provides countries with practical and adaptable resources, including planning materials, job aids, standard operating procedures, monitoring and evaluation spreadsheets, training slides, training and competency checklists, a capacity calculator, and quality assurance materials to support effective, scalable and quality-assured implementation of WHO recommendations in alignment with setting-specific national guidelines.

This TB Vaccine Advocacy Roadmap (TB Vax ARM) webinar took place on Wednesday 11 March to begin a conversation exploring the factors that will shape access to new TB vaccines. Together, we‚ are working to define common civil society priorities‚ green lines, for access conditions in TB vaccine agreements to inform work by groups such as the TB Vaccine Accelerator Council‚Äôs Finance and Access Working Group. The objectives of this webinar were to: Begin to develop a shared understanding of factors that will shape access for new TB vaccines Begin to come together around common civil society priorities regarding access conditions for TB vaccine agreements to inform work by actors including the TB Vaccine Accelerator Council Finance and Access Working Group and the proposed catalytic instrument

This recorded webinar is a presentation by Erin McConnell from Treatment Action Group. She discusses research advocacy specifically for TB scientists.

The NIAID Stats Calculator application is provided by the Bioinformatics and Computational Biology Branch to allow users to perform quick sanity checks when exploring experimental results data. Please refer to the website for the details.

The NIAID Data Ecosystem Discovery Portal is a centralized search hub for infectious and immune-mediated disease datasets and computational tools from over 70 sources. These include NIAID-funded repositories as well as globally-relevant infectious and immune-mediated disease (IID) repositories from NIH and beyond. Resources in the Discovery Portal include -omics data, clinical data, epidemiological data, pathogen-host interaction data, flow cytometry, imaging, workflows, computational tools, and more. The NIAID Data Ecosystem Discovery Portal does not store data. Instead, it contains harmonized and detailed information (metadata) about datasets, computational tools, and resources. Users can then navigate to datasets, tools, and resources through external links.